U.S. market Open. Closes in 3 hours 45 minutes

BBH | VanEck Biotech ETF Holdings

(Stock Exchange: NASDAQ)
Symbol Name Market Cap Weight Valuation Profitability Growth Health 200SMA Price Change IV IV Rank
AMGN Amgen Inc. 180.59B 15.48%
336.09 0.95% 26.21% 30.95%
VRTX Vertex Pharmaceuticals Incorporated 123.67B 9.73%
479.14 1.05% 25.67% 48.32%
REGN Regeneron Pharmaceuticals, Inc. 125.81B 8.49%
1,160.46 1.90% 25.78% 44.23%
GILD Gilead Sciences, Inc. 105.01B 8.21%
84.34 0.54% 22.75% 21.24%
ARGX argenx SE 31.99B 5.90%
535.04 1.13% 27.93% 5.11%
IQV IQVIA Holdings Inc. 44.69B 5.13%
245.15 1.02% 29.03% 51.14%
ILMN Illumina, Inc. 21.47B 4.18%
134.79 2.92% 40.22% 13.51%
BGNE BeiGene, Ltd. 22.28B 4.05%
200.77 1.77% 33.80% 15.54%
ICLR ICON Public Limited Company 25.17B 3.88%
303.93 0.49% 33.12% 37.58%
BIIB Biogen Inc. 29.35B 3.63%
201.52 1.99% 27.31% 24.65%
ALNY Alnylam Pharmaceuticals, Inc. 35.84B 3.46%
279.15 2.19% 36.97% 23.68%
NTRA Natera, Inc. 15.97B 2.94%
129.12 1.59% 39.92% 23.32%
BNTX BioNTech SE 26.60B 2.90%
111.90 -3.22% 45.40% 53.18%
NBIX Neurocrine Biosciences, Inc. 12.35B 2.40%
122.34 2.07% 29.90% 13.36%
TECH Bio-Techne Corporation 12.66B 2.29%
79.83 4.34% 26.74% 34.72%
EXAS Exact Sciences Corporation 13.14B 2.24%
71.12 2.75% 49.71% 18.06%
MRNA Moderna, Inc. 26.83B 2.19%
69.79 -0.11% 60.70% 69.28%
SRPT Sarepta Therapeutics, Inc. 12.22B 2.17%
128.12 2.49% 40.23% 2.28%
QGEN Qiagen N.V. 10.19B 2.14%
45.93 0.55% 37.62% 47.89%
CRL Charles River Laboratories International... 10.95B 2.07%
212.07 2.90% 35.18% 52.27%
BMRN BioMarin Pharmaceutical Inc. 13.53B 2.01%
71.05 -0.13% 29.47% 28.07%
INCY Incyte Corporation 12.77B 1.51%
66.31 1.75% 21.51% 37.71%
RGEN Repligen Corporation 8.30B 1.37%
148.15 4.31% 59.79% 80.21%
CRSP CRISPR Therapeutics AG 4.33B 0.80%
50.82 2.48% 56.34% 13.85%
CYTK Cytokinetics, Incorporated 6.58B 0.72%
55.89 -0.10% 69.03% 13.96%
GRAL Grail Inc 0.08%
Other/Cash 0.06%
Total holdings: 27 Recognized Stocks: 25 Others: 2
An error has occurred. This application may no longer respond until reloaded. Reload 🗙